Slipstream™ Platform for High-Efficiency Manufacturing of Deep-Primed T-Cell Therapies

Streamlined, scalable T cell manufacturing system

Slipstream™ is a proprietary, high-efficiency T cell manufacturing platform engineered by Torque to operate as modular compact factories. Currently marketed immune cell therapies are produced using open, complex, labor- and cost-intensive processes that require a substantial manufacturing facility. In contrast, Slipstream production is semi-automated, modular, and scalable and can dramatically reduce staffing requirements and the factory footprint.

Using proprietary processes, automation, and advanced logistics, we innovated the Slipstream process for high-efficiency use of space and labor. The system is also designed to be fully closed to eliminate contamination between transfers, and this will be implemented as Torque moves into later-stage clinical trials. Our goal is to deliver the highest-quality end product for patients.

Torque Slipstream Factory

The Slipstream production line can be used in both large-scale and decentralized manufacturing settings, with the potential to move cell manufacturing closer to the point of care. Production capacity can be expanded by adding additional arrays in Lego-like fashion.



Deep-Primed Immune Cell Therapy Process

Torque Deep-Primed T Cell Therapeutic Development

Back to Top